Women have made a good deal of welcome progress in the last several decades, but at least one advance is unwanted: chronic obstructive pulmonary disease (COPD) is on the rise in women in prevalence, morbidity and mortality. By 2000, the number of women dying from COPD surpassed the number of men.

A new study presented today showed that ramelteon did not exacerbate respiratory depressant effects in patients (40 years and older) with moderate to severe chronic obstructive pulmonary disease (COPD), as measured by oxygenation or abnormal breathing events relative to placebo.

Smoking is a more harmful behavior for women compared to men, especially in regards to the risk of developing COPD.

Data from two Phase III clinical trials were presented today in Chicago at CHEST 2007, the annual scientific assembly of the American College of Chest Physicians (ACCP), supporting the use of Perforomist™ (formoterol fumarate) Inhalation Solution as a safe and effective maintenance treatment for COPD patients. The results of both studies were included as part of the New Drug Application (NDA) filing to the U.S. Food and Drug Administration (FDA) for Perforomist™ Inhalation Solution.

One out of three patients with asthma or chronic obstructive pulmonary disease (COPD) use their inhalers incorrectly, a new study shows.

In China, chronic obstructive pulmonary disease (COPD) in people over the age of 40 is much more prevalent than previously thought, according to researchers in Guangdong.

Applied Data Research Analyzes the Potential of User-Friendly Combination Products

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has released new standards for the diagnosis, management and prevention of chronic obstructive pulmonary disease (COPD). The latest recommendations emphasize the importance of proper diagnosis, assessment of the disease’s severity, and the need for a better understanding of co-morbidities to improve treatment of disease.

Two worldwide studies published in this week's edition of The Lancet observe the alarming growth rate of chronic obstructive pulmonary disease (COPD). The only U.S. site in the International Burden of Lung Disease (BOLD) Study was located in Eastern Kentucky, and was found to have some of the highest rates of COPD in the world. In fact, it had the second highest rate among women and fourth highest among men.

Prescribing ambulatory oxygen in patients with chronic obstructive pulmonary disease (COPD) improves exercise performance, but not the quality of their daily life unless they have resting hypoxemia, according to researchers in Toronto.

Spirometry testing is a widely accepted and encouraged diagnostic method for chronic obstructive pulmonary disease (COPD), but new research shows that it is not used nearly enough. The study appears in the August issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP) and reports that only one-third of patients with a COPD diagnosis ever received spirometry testing.

A new study reveals that in men with chronic obstructive pulmonary disease (COPD), at all stages of severity, men have more CT-measurable emphysema than women with COPD.